Showing results (431-440 of 489) with videos related to

Sort By:
Pageof 49
American Journal of Respiratory and Critical Care Medicine|February 15, 2018
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical TrialKen M Kunisaki, Mark T Dransfield, Julie A Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2012
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseBartolome R Celli, Nicholas Locantore, Julie Yates, et al.
The European Respiratory Journal|June 15, 2013
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortAlvar Agusti, Lisa D Edwards, Bartolomé Celli, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized TrialsFernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
COPD|May 17, 2014
Evaluating the role of inflammation in chronic airways disease: the ERICA studyDivya Mohan, Nichola S Gale, Carmel M McEniery, et al.
The Lancet. Respiratory Medicine|December 7, 2019
Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trialAlison J Wimms, Julia L Kelly, Christopher D Turnbull, et al.
The European Respiratory Journal|December 11, 2020
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohortBartolome Celli, Nicholas Locantore, Julie C Yates, et al.
Respiratory Medicine|June 25, 2013
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortJoy Miller, Lisa D Edwards, Alvar Agustí, et al.
Thorax|July 17, 2015
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trialSimon E Brill, Martin Law, Ethaar El-Emir, et al.
ERJ Open Research|July 29, 2021
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trialEmily P Brigham, Julie A Anderson, Robert D Brook, et al.
Pageof 49